Answers are grounded in this paper and cite their sources.
This study suggests S6K2 and 4EBP1 as important factors for breast tumourigenesis, interplaying with hormone receptor signalling. We propose S6K2 and 4EBP1 as new potential clinical markers for prognosis and endocrine therapy response in breast cancer.
No takes yet. Share an insight, caveat, or question.
Karlsson et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: